Cogent Biosciences Statistics
Total Valuation
COGT has a market cap or net worth of $5.90 billion. The enterprise value is $5.57 billion.
Important Dates
The last earnings date was Monday, November 3, 2025, before market open.
| Earnings Date | Nov 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
COGT has 152.13 million shares outstanding. The number of shares has increased by 21.79% in one year.
| Current Share Class | 152.05M |
| Shares Outstanding | 152.13M |
| Shares Change (YoY) | +21.79% |
| Shares Change (QoQ) | +20.15% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 86.23% |
| Float | 116.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 27.88 |
| P/TBV Ratio | 30.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.38, with a Debt / Equity ratio of 0.20.
| Current Ratio | 6.38 |
| Quick Ratio | 6.28 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -173.49 |
Financial Efficiency
Return on equity (ROE) is -95.40% and return on invested capital (ROIC) is -55.28%.
| Return on Equity (ROE) | -95.40% |
| Return on Assets (ROA) | -47.47% |
| Return on Invested Capital (ROIC) | -55.28% |
| Return on Capital Employed (ROCE) | -84.58% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.44M |
| Employee Count | 205 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +320.96% in the last 52 weeks. The beta is 0.51, so COGT's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +320.96% |
| 50-Day Moving Average | 23.52 |
| 200-Day Moving Average | 12.14 |
| Relative Strength Index (RSI) | 76.50 |
| Average Volume (20 Days) | 4,702,910 |
Short Selling Information
The latest short interest is 15.48 million, so 10.17% of the outstanding shares have been sold short.
| Short Interest | 15.48M |
| Short Previous Month | 15.05M |
| Short % of Shares Out | 10.17% |
| Short % of Float | 13.28% |
| Short Ratio (days to cover) | 3.66 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -307.60M |
| Pretax Income | -294.37M |
| Net Income | -294.37M |
| EBITDA | -305.04M |
| EBIT | -307.60M |
| Earnings Per Share (EPS) | -$2.47 |
Full Income Statement Balance Sheet
The company has $390.89 million in cash and $60.56 million in debt, giving a net cash position of $330.33 million or $2.17 per share.
| Cash & Cash Equivalents | 390.89M |
| Total Debt | 60.56M |
| Net Cash | 330.33M |
| Net Cash Per Share | $2.17 |
| Equity (Book Value) | 302.46M |
| Book Value Per Share | 1.39 |
| Working Capital | 335.00M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$245.92 million and capital expenditures -$818,000, giving a free cash flow of -$246.73 million.
| Operating Cash Flow | -245.92M |
| Capital Expenditures | -818,000 |
| Free Cash Flow | -246.73M |
| FCF Per Share | -$1.62 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
COGT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.79% |
| Shareholder Yield | -21.79% |
| Earnings Yield | -4.99% |
| FCF Yield | -4.18% |
Dividend Details Analyst Forecast
The average price target for COGT is $28.08, which is -27.57% lower than the current price. The consensus rating is "Buy".
| Price Target | $28.08 |
| Price Target Difference | -27.57% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 9, 2020. It was a reverse split with a ratio of 1:4.
| Last Split Date | Nov 9, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |